Catalyst Clinical Research
Lydia King, PhD, MPH, is a seasoned biostatistician and epidemiologist with extensive experience in clinical research, currently serving as the Director of Biostatistics at Catalyst Clinical Research, LLC since August 2016. Lydia has a robust consulting practice, providing statistical expertise for Phase I-IV trials and authoring Statistical Analysis Plans and Clinical Study Reports. Prior roles include significant contributions as a Biostatistician at NCGS, Inc. and Assistant Professor at the Medical University of South Carolina, where Lydia specialized in Autism Spectrum Disorders, managed large-scale studies, and instructed graduate students. Educational credentials include a PhD in Epidemiology from the Medical University of South Carolina and an MPH from Emory University, complemented by a BS in Microbiology from the University of Alabama.
This person is not in any offices
Catalyst Clinical Research
2 followers
Catalyst Clinical Research is a provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company was built on more than two decades of experience in assisting clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions.